pros and cons of retatrutide Cons: What Canadians Need to Know retatrutide mechanism triple agonist glp-1
Description
Koole C, Pabreja K, Savage Emilia E, Wootten D, Furness Sebastian GB, Miller Laurence J, et al

Huberman has also publicly discussed the difference between medications developed through regulated research and products obtained through questionable gray-market sources

Current Obesity Reports, 14 (1), 45

In Langer's preclinical mouse work, this turned out to be enormous

Rather than simply prescribing medications, we combine microdosing with guidance on nutrition and physical activity, cardiovascular health monitoring, and ongoing support to help patients achieve results safely

That averages out to a 5% weight loss without even utilizing the maximally tolerated dose
